Economic Burden of Pediatric Asthma: Annual Cost of Disease in Iran
AbstractBackground: Asthma is the first cause of children hospitalization and need for emergency and impose high economic burden on the families and governments. We aimed to investigate the economic burden of pediatric asthma and its contribution to family health budget in Iran.Methods: Overall, 283 pediatric asthmatic patients, who referred to two tertiary pediatric referral centers in Tehran capital of Iran, included from 2010-2012. Direct and indirect asthma-related costs were recorded during one-year period. Data were statistically analyzed for finding association between the costs and factors that affect this cost (demographic variables, tobacco smoke exposure, control status of asthma and asthma concomitant diseases).Results: Ninety-two (32.5%) females and 191(67.5%) males with the age range of 1-16 yr old were included. We found the annual total pediatrics asthma related costs were 367.97±23.06 USD. The highest cost belonged to the medications (69%) and the lowest one to the emergency (2%). We noticed a significant increasing in boys’ total costs (P=0.011), and 7-11 yr old age group (P=0.018). In addition, we found significant association between total asthma costs and asthma control status (P=0.011).Conclusion: The presence of an asthmatic child can consume nearly half of the health budget of a family. Our results emphasis on improving asthma management programs, which leads to successful control status of the disease and reduction in economic burden of pediatric asthma.
Omrani GR, Kargar F, Aazami MH (2006). Intra-pericardial hydatid cyst seen by dynamic computed tomography. Eur J Cardiothorac Surg, 30:805.
Holgate ST, Wenzel S, Postma DS, Weiss ST, Renz H, Sly PD (2015). Asthma. Nat Rev Dis Primers, 1:15025.
Fakhar M, Sadjjadi SM (2007). Prevalence of hydatidosis in slaughtered herbivores in Qom province, central part of iran. Vet Res Commun, 31:993-7.
Vos T, Flaxman AD, Naghavi M et al (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380:2163-96.
Masoli M, Fabian D, Holt S, Beasley R (2004). The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy, 59:469-78.
Braman SS (2006). The global burden of asthma. Chest, 130:4S-12S.
Saidi F (2005). How to manage asymptomatic liver hydatids. Arch Iranian Med, 9:173-4.
Sullivan S, Elixhauser A, Buist AS, Luce BR, Eisenberg J, Weiss KB (1996). National Asthma Education and Prevention Program working group report on the cost effectiveness of asthma care. Am J Respir Crit Care Med, 154:S84-95.
Ismaila AS, Sayani AP, Marin M, Su Z (2013). Clinical, economic, and humanistic burden of asthma in Canada: a systematic review. BMC Pulm Med, 13:70.
Azordegan N, Yazdankhah A, Pouraliakbar H (2007). Hydatid disease of the spleen (report of 2 cases). Travel Med Infect Dis, 5:60-1.
Anonymus (1998). Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J, 12:315-35.
Fowler MG, Davenport MG, Garg R (1992). School functioning of US children with asthma. Pediatrics, 90:939-44.
Van Wonderen KE, Van Der Mark LB, Mohrs J, Bindels PJ, Van Aalderen WM, Ter Riet G (2010). Different definitions in childhood asthma: how dependable is the dependent variable? Eur Respir J, 36:48-56.
Lai CK, Beasley R, Crane J et al (2009). Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax, 64:476-83.
Entezari A, Mehrabi Y, Varesvazirian M ,Pourpak Z, Moin M (2009). A systematic review of recent asthma symptom surveys in Iranian children. Chron Respir Dis, 6:109-14.
Ernst R (2006). Indirect costs and cost-effectiveness analysis. Value Health, 9:253-61.
Bahadori K, Doyle-Waters MM, Marra C et al (2009). Economic burden of asthma: a systematic review. BMC Pulm Med, 9:24.
Sharifi L, Pourpak Z, Fazlollahi MR et al (2015). Asthma Economic Costs in Adult Asthmatic Patients in Tehran, Iran. Iran J Public Health, 44:1212-8.
Ghorbanpoor M, Razi Jalali MH, Hoghooghi Rad N et al (2006). Detection of specific hydatid antigens and antibodies in serum and urine of experimentally infected sheep. Vet Parasitol, 142:91-4.
Dalimi A, Motamedi G, Hosseini M et al (2002). Echinococcosis/hydatidosis in western Iran. Vet Parasitol, 105:161-71.
Barnett SB, Nurmagambetov TA (2011). Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol, 127:145-52.
Cisternas MG, Blanc PD, Yen IH et al (2003). A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol, 111:1212-8.
Ungar WJ, Coyte PC (2001). Prospective study of the patient-level cost of asthma care in children. Pediatr Pulmonol, 32:101-8.
Stevens CA, Turner D, Kuehni CE, Couriel JM, Silverman M (2003). The economic impact of preschool asthma and wheeze. Eur Respir J, 21:1000-6.
Antonicelli L, Bucca C, Neri M et al (2004). Asthma severity and medical resource utilisation. Eur Respir J, 23:723-9.
Stock S, Redaelli M, Luengen M, Wendland G, Civello D, Lauterbach KW (2005). Asthma: prevalence and cost of illness. Eur Respir J, 25:47-53.
Weiss KB, Sullivan SD (2001). The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol, 107:3-8.
Weiss KB, Sullivan SD, Lyttle CS (2000). Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol, 106:493-9.
Rezvanfar MA, Kebriaeezadeh A, Moein M, Nikfar S, Gharibnaseri Z, Abdollahi-Asl A (2013). Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies. J Res Pharm Pract, 2:162-8.
Dashti R, Sedighy M, Pourpak Z, Ahmadiani MS, Fazlollahi MR, Bavarian B, Moin M (2013). Direct economic cost of acute asthma in emergency department. Indian J Pediatr, 80:708-9.
Maleky F, Moradkhan M (2000). Echinococcosis in the stray dogs of Tehran, Iran. Ann Trop Med Parasitol, 94:329-31.
Lozano P, Sullivan SD, Smith DH, Weiss KB (1999). The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol, 104:957-63.
Kim SH, Kim TW, Kwon JW et al (2012). Economic costs for adult asthmatics according to severity and control status in Korean tertiary hospitals. J Asthma, 49:303-9.
Accordini S, Bugiani M, Arossa W et al (2006). Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol, 141:189-98.
Kauppi P, Linna M, Martikainen J, Makela MJ, Haahtela T (2013). Follow-up of the Finnish Asthma Programme 2000-2010: reduction of hospital burden needs risk group rethinking. Thorax, 68:292-3.
Boulet LP (2009). Influence of comorbid conditions on asthma. Eur Respir J, 33:897-906.
Burke H, Leonardi-Bee J, Hashim A et al (2012). Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics, 129:735-44.
Horwood LJ, Fergusson DM, Shannon FT (1985). Social and familial factors in the development of early childhood asthma. Pediatrics, 75:859-68.
Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ (1995). Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med, 332:133-8.
Pedersen SE, Hurd SS, Lemanske RF et al (2011). Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatr Pulmonol, 46:1-17.